Indivior Pharmaceuticals Inc
Healthcare · Drug Manufacturers - Specialty & Generic · $4.59B market cap · Ranked #116 of 1,207
Scores well above the universe median on the composite. Ranks in the 90th percentile overall.
Nothing notable on this side.
Nothing notable on this side.
Figures come straight from the company’s filed quarterly report and feed the six-factor model (growth, quality, and value especially). This is a summary of what was reported — research, not a recommendation, and there are no analyst estimates behind it, so it isn’t a beat-or-miss call.
The latest raw values feeding the six factors.
Every rating we’ve ever assigned INDV — append-only and hash-verified. We don’t revise or delete past calls.
2 rating changes across 103 snapshots — each with the factor shift that drove it.
The full append-only record of every call we’ve made on INDV— the accountability history mainstream sites quietly edit and we can’t — is part of Proofstock Plus.
Unlock with Plus